New drug shows promise in battle against ALS

To view this site, you need to have Flash Player 9.0.115 or later installed. Click here to get the latest Flash player.

August 20, 2012, 8:40 pm
SHARE THIS POST
Print Article


(NECN) - A new drug from a local company, Biogen, is showing promise in the battle against Lou Gehrig's disease, or ALS.

That is the topic of this week's cover story in the Boston Business Journal. There are just 30,000 patients with ALS in the country and the article focuses on one of them. The author of the article, Julie Donnelly, joins us in the studio to discuss her piece and the potential new drug.

Watch the attached video for more.

Tags: Boston Business Journal, ALS, Biogen, Lou Gehrig's disease
RELATED STORIES
COMMENTS
chism
Philip Chism is charged with attacking a female DYS worker while awaiting his trial in the death of Colleen Ritzer
Norma Dimick of Stratford, NH, was last seen leaving her home on foot Tuesday
MIT Officer Sean Collier was allegedly murdered by the Boston Marathon bombing suspects 4 days after the attack